Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06371807
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-17
First Post:
2024-03-12
Brief Title:
Trial for Treatment of High Risk BC With Two Sequences of Neoadjuvant Chemotherapy With Pembrolizumab
Sponsor:
Fundacao Champalimaud
Organization:
Fundacao Champalimaud
Organization Data
Organization:
Fundacao Champalimaud
Class:
OTHER
Study ID:
EU CTR nº 2023-507008-30-00
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fundacao Champalimaud
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None